Ambev S.A. (ABEV) Stock

About Ambev S.A.

Ambev S.A., operating through its various subsidiaries, is a prominent player in the beverage and food industry across the Americas. The company is engaged in the manufacturing, marketing, and distribution of a diverse portfolio of products, including various types of beer (both packaged and on tap), carbonated soft drinks, other non-alcoholic beverages, malt, and food items. Its extensive operations are structured into four primary geographical divisions: Brazil; Central America and the Caribbean; Latin America South; and Canada. Ambev's vast selection of beer labels features widely recognized names such as Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Bud Light, Beck, Leffe, Hoegaarden, Bucanero, Cristal, Mayabe, Cacique, Presidente, Brahma Light, Presidente Light, Presidente Golden Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Budweiser, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee. Beyond alcoholic offerings, the company also provides a comprehensive range of non-alcoholic drinks. These include bottled water, isotonic and energy beverages, coconut water, powdered and natural fruit juices, and ready-to-drink teas. These products are sold under popular brands like Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi, Canada Dry, Squirt, Red Rock, Pepsi-Cola, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's. Products are made available to consumers through a multifaceted distribution approach, combining its own direct distribution network with a system that leverages third-party distributors. Ambev S.A. was founded in 1885 and maintains its corporate headquarters in São Paulo, Brazil. It operates as a subsidiary of Interbrew International B.V.

Ambev S.A. is headquartered in BR.

Ambev S.A. (ABEV) stock trades at $3.07 with a market capitalization of $47.88B. The stock is valued at a price-to-earnings (P/E) ratio of 15.98, price-to-book of 2.74, price-to-sales of 2.80. Over the past 52 weeks the stock has ranged between $2.10 and $3.45, and currently trades 11.0% below its 52-week high.

On profitability, Ambev S.A. generates a return on equity (ROE) of 17.19%, above the typical market range of roughly 12-15%, return on capital employed of 21.48%, an operating margin of 25.31%, a net profit margin of 17.66%.

In its most recent fiscal year, Ambev S.A. reported annual revenue of $88.2B, net profit of $15.5B. Over the last 5 fiscal years, revenue grew at an average annual rate of 8.6%, and net profit grew at an average annual rate of 6.4%.

The balance sheet shows a debt-to-equity ratio of 0.03 (debt below half of shareholders' equity), a current ratio of 1.03, total assets of $148.1B, $18.6B in cash and equivalents.

ABEV has an average daily trading volume of 27,178,829 shares, a beta of 0.27 (historically less volatile than the overall market).

Official website: www.ambev.com.br

Ambev S.A. by the numbers, 2016–2025

Between 2016 and 2025 Ambev S.A. reported revenue of $45.6B rising to $88.2B, a change of +93.5% across 10 years. Compounded, revenue has grown 8.6% a year over five years, 3.5% over three, -1.4% over the last twelve months. Net profit rose to $15.5B.

Operating margin went from 37.5% in 2016 to 25.3% in 2025, a fall of 12.2 percentage points. The most recent net margin is 17.66%. On a trailing twelve-month basis to Mar '26, revenue is $88.2B and net profit $15.6B.

Borrowings held roughly flat from $5.4B to $5.3B, cash on hand is $19.6B, cash from operations was $24.4B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 16.7% over five years, and was 17.6% in the most recent year.

The share price itself has compounded at —% a year over five years, 5.5% over three, 32.9% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Ambev S.A. (ABEV) — frequently asked questions